0-Mo | Registry of Clotting Factor Concentrates | Mark Brooker | Received |
1-We | Prevalence of Cardiovascular Disease or its Equivalents in Patients withInherited Coagulopathies | M. CEM AR | Received |
2-Mo | Patterns of bleeding, comorbidities and clinical courses in Acquired HemophiliaA(AHA) and in Acquired von Willebrand Disease (AVWD): experience from a singleHemophilia Center of Pavia | Gabriella Gamba | Received |
2-We | Carotid endarterectomy in two persons with Haemophilia | Louise Bowles | Received |
3-We | DESCRIBING OCCURRENCE OF CORONARY EVENTS AND TREATMENT IN HAEMOPHILIACS (DOCETHREGISTRY): REPORT OF 27 PATIENTS. | Antonio Coppola | Received |
3-Mo | Acquired hemophilia - clinical course and treatment outcomes in 25 patients | Denisa Jankovicova | Received |
4-LB | Trends in invasive orthopedic interventions for individuals with a bleeding disorder enrolled in the Universal Data Collection | Patricia Tobase | Received |
4-Mo | ACQUIRED HAEMOPHILIA AT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL | MOOSA PATEL | Received |
4-Tu | INTEGRATING AGEING WITH A BLEEDING DISORDER INTO CANADIAN HEMOPHILIA SOCIETY(CHS) STRATEGIES | Clare Cecchini | Received |
5-We | Cataract surgery in haemophilia | Dietje Fransen van de Putte | Received |
6-Tu | THE IMPORTANCE OF MULTIDISCIPLINARY APPROACH TO PATIENTS WITH HEMOPHILIA | Glbahar Keskin | Received |
6-We | Ageing and quality of life in persons with hemophilia | Marko Marinic | Received |
7-We | Nursing the aging haemophiliac:Cardiovascular challenges | Cathy Mumby | Received |
7-Mo | HIGH DOSE OF FVIII CONCENTRATE AS FIRST LINE THERAPY IN FOUR PATIENTS AFFECTEDBY ACQUIRED HAEMOPHILIA A AND CARDIOVASCULAR DISEASE | Ezio Zanon | Received |
7-Tu | A Recruitment Plan for Volunteers | Brian OMahony | Received |
8-Tu | Canadian Hemophilia Society Involvement in Canadas Blood System | David Page | Received |
8-We | Newly emerging problems among aging patients with hemophilia in Japan | Azusa Nagao | Received |
9-We | The Elderly Hemophilia Population - A Nordic Patient Organisation Prospective | Suzanne Ceder | Received |
10-We | Patterns of gastrointestinal hemorrhage in hemophilia. | ajmi naourez | Received |
11-We | The medical and economic burden of mild hemophilia in comparison to the severetype: long term data from a german single center | Christoph Bidlingmaier | Received |
12-Tu | Prospective and challenges of pediatric hematology at KFSH&RC, Riyadh, Saudi Arabia | MAHASEN SALEH | Received |
12-We | Technical issues in implementing prophylaxis in children with hemophilia: aninternational survey | Christoph Bidlingmaier | Received |
13-Tu | Impact of training the trainers in haemophilia care in Pakistan | Tahira Zafar | Received |
14-Mo | The European Haemophilia Network (EUHANET) project | Michael Makris | Received |
14-We | CAUSES OF DEATH IN PATIENTS WITH HEMOPHILIA ATTENDED AT THE NATIONAL HEMOPHILIACENTER OF VENEZUELA (1989- 2011) | Apsara Boadas de Sanchez | Received |
15-Tu | EXPERIENCE IN THE TREATMENT OF CUBAN PATIENTS WITH SEVERE BLEEDING USINGRECOMBINANT FVIIA | Dunia de la Caridad Castillo González | Received |
15-We | CARDIAC SURGERY IN HAEMOPHILIACS : REPORT OF 14 CONSECUTIVE CASES | Marie-Elisabeth Briquel | Received |
16-Mo | Patient Organisation involvement in management of Hepatitis C | Brian OMahony | Received |
17-Mo | Muoviamoci (Italian Musculoskeletal Global Project) | Gianluigi Pasta | Received |
18-Mo | Fostering collaboration in hemophilia care | Jayson Stoffman | Received |
19-We | Evaluation of the utilization of factor concentrate and frequency of bleedsamong the patients with severe and moderate Factor VIII and Factor IX deficiency | Roya Dolatkhah | Received |
19-Mo | Mild Haemophilia may hide severe haemophilia. | Philippe BEURRIER | Received |
20-Tu | Variable Activation Kinetics of Different Recombinant Full Length and B-DomainDeleted Factor VIII Concentrates | Saskia Pahl | Received |
20-Mo | Pregnancy outcome in haemophilia A carriers over a 5 year period in a UKHaemophilia Comprehensive care centre (CCC) | Deepa Ranjani Jayakody Arachchillage | Received |
21-We | Usefulness of Multidetector Computed Tomography Angiography (MDCTA) inhemophilic patients previous to embolization of the middle geniculate artery(MGA) | Matilde Hernandez-Trejo | Received |
21-Tu | One Year Clinical Experience with Mini-Pool Solvent/Detergent-filtered (SD-F)Plasma | El Ekiaby Magdy | Received |
23-We | Comprehensive Spectrum of inherited bleeding disorders from South West Iran | Bijan Keikhaei | Received |
24-We | Role of angiogram and embolisation in patients with haemophilia | Shyamkumar Keshava | Received |
25-Mo | Hemophilia in Taiwan: a Population-Based Study on Epidemiology, Age atDiagnosis, Mortality, and 13-year Trend by National Health Insurance ResearchDatabase 1997-2009 | Chia-Yau Chang | Received |
25-Tu | CTP - A CLINICALLY VALIDATED TECHNOLOGY FOR ELONGATING THE HALF LIFE OF COAGULATION FACTORS, ENABLING A PROLONGED HAEMOSTATIC ACTIVITY IN HEMOPHILIC ANIMAL MODEL | Gili Hart | Received |
26-We | Obesity and Haemophilia - Review of an MDT weight management service. | Paul McLaughlin | Received |
29-Mo | Updating the National Registry of People with clotting deficiencies in Mexico | Carlos Gaitán-Fitch | Received |
29-We | Correcting Dilutional Coagulopathy in Haemophilia | Renu Riat | Received |
30-We | Prevalence of sporadic and familial severe haemophilia: is anything changed? | riccardi federica | Received |
30-Tu | Analysis of the Composition of a Factor VIII Concentrate, Optivate | Sarah Kingsland | Received |
31-We | CLINICAL AND EPIDEMIOLOGICAL PROFILE OF CONGENITAL COAGULOPATHY PATIENTSATTENDING AT GENERAL EMERGENCY DEPARTMENT | M. Angelica Rivera | Received |
33-Mo | Long-term course of the severe haemophilia A or B patients in Sweden: Results from a cohort register study | Susanna Lvdahl | Received |
33-Tu | In vitro reversal of the direct Xa inhibitor Rivaroxaban using High Purityfactor X concentrate (FACTOR X) | Joanne Lloyd | Received |
34-Tu | In vitro Characterisation of FACTOR X in Global Haemostasis Tests | Joanne Lloyd | Received |
34-Mo | REALITY OF THE HEMOPHILIAS IN PANAMA | MORENO BELGICA | Received |
35-We | Hemophilia in developing countries: clinical profile of Cameroonian patients | Tayou Tagny Claude | Received |
35-Mo | Australian Bleeding Disorders Registry(ABDR) - an update | Joihn Rowell | Received |
36-Tu | Repeated Application of a new Recombinant Factor IX in Rats and Macaques | Eva Muchitsch | Received |
37-Tu | Preclinical Safety of a new Recombinant Factor VIIa | Eva Muchitsch | Received |
38-Tu | Safety of a PEGylated variant of recombinant factor VIII after repeated application in rats and macaques | Eva Muchitsch | Received |
39-Tu | Absorption, Metabolism, Distribution, and Excretion of a PEGylated Variant ofRecombinant Factor FVIII Following Intravenous Administration to Rats | Eva Muchitsch | Received |
39-We | Intracranial bleeds in bleeding disorders: a Northern Pakistan experience | Tahira Zafar | Received |
40-Tu | Pharmacokinetics (PK) of recombinant and plasma-derived factor VIII (FVIII) products in pediatric patients with severe hemophilia A | Melanie Steele | Received |
41-We | The importance of the pediatric hemostaseologist:cohort of pediatrichemostaseology patients in a tertiary german out-patient center | Sabine Irene Heine | Received |
42-We | Synoviorthesis with rifampicin as a adjuvant treatment of hemophilic arthropathy | Pan Ru-Yu | Received |
43-Tu | Roman Numerals to Denote Clotting Factors: A Potential Source of Medical Errors | David Page | Received |
43-We | Nutritional study in haemophilic patients by using social networks | Gianluca Sottilotta | Received |
43-Mo | National plan of control of heamophilia. The Moroccan national plan | El Khorassani Mohamed | Received |
44-Mo | Cost assessment of implementation of ITI in Iran | PEYMAN ESHGHI | Received |
44-Tu | CRYOPRECIPITATE TRANSFUSION IN ON-PUMP CARDIAC SURGERY | Katerina Pavenski | Received |
44-We | Experience on the management of malignancy in hemophilia patients. | Paula Villaca | Received |
45-Mo | Evidence for mobilizing policy on hemophilia in India : I. Utility of hemophiliaregistry data from Maharashtra, 1989-2009 | Anita Kar | Received |
45-Tu | Characterization of the binding properties of recombinant FVIII concentrateswith von Willebrand Factor | Daniele Pillitteri | Received |
46-Mo | Evidence for mobilizing policy on hemophilia in India: II. An estimate of treatment gap in Maharashtra | Anita Kar | Received |
46-Tu | Factor XIII levels in Haemophilia; Treatment Implications | Ole Halfdan Larsen | Received |
47-We | Nutritional Intake and Bone Mineral Density in Boys with Severe Hemophilia. | Cecily Bos | Received |
47-Mo | Indirect Costs Among Persons With Hemophilia B: Hemophilia Utilization Group Study Part Vb (HUGS Vb) | Mimi Lou | Received |
48-We | Low Bone Mineral Density and Increased Fat Mass in Boys with Severe Hemophilia. | Cecily Bos | Received |
48-Tu | Efficacy of a Recombinant Factor IX in Mouse Models of Hemophilia B | Eva-Maria Muchitsch | Received |
48-Mo | Economic impact of an efficient inclusive national tender system for factorconcentrates | Brian OMahony | Received |
49-Tu | Efficacy of a New Recombinant Factor VIIa in Animal Models of Hemophilia | Eva-Maria Muchitsch | Received |
49-Mo | Characterising Excessive School and Work Absenteeism in Hemophilia A: Hemophilia Utilization Group Study Part Va (HUGS Va) | Jiat Ling Poon | Received |
50-Tu | Efficacy of a PEGylated Variant of Recombinant Factor VIII in Mouse Models ofHemophilia A | Eva-Maria Muchitsch | Received |
50-Mo | A NEW METHODOLOGY TO ASSESS UTILITY IN HAEMOPHILIA USING QUALITY OF LIFEMEASURES IN PARENTS AND CAREGIVERS: THE CAREGIVERS BURDEN STUDY | silvia riva | Received |
51-Mo | COST OF IMMUNE TOLERANCE INDUCTION IN HEMOPHILIA A PATIENTS: RESULTS FROM THE ITER STUDY | silvia riva | Received |
52-Mo | PHARMMACOECONOMIC EVALUATION WITH AN ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE(APCC) IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS (PRO-FEIBA STUDY) | silvia riva | Received |
52-Tu | Collaborative Study for the Establishment of Korean Standard for Blood Products(Factor IX Concentrate) | JiSuk Seo | Received |
52-We | Managing major surgical operations in a large haemophilia centre in NorthernIndia | Naresh Gupta | Received |
53-Mo | COST OF ILLNESS ANALYSIS OF HAEMOPHILIA A: RESOURCES USE AND DIRECT COSTS INITALY | Michele Schino | Received |
53-Tu | The stability of FVIII in cold condition | Rahajuningsih Dharma Setiabudy | Received |
54-Tu | A case of inhibitor to factor IX in a two years old boy with severe congenitalhaemophilia B. | skhiri rania | Received |
55-Mo | Budget impact of FVIII concentrates taking into account the incidence of de novoinhibitor formation in PTPs: a breakeven analysis applied to ADVATE in theItalian context. | Giuseppe Turchetti | Received |
56-Mo | A cost-effective provincial redistribution system to prevent wastage of clottingfactor concentrates | Sarah Crymble | Received |
57-Tu | 2D-DIGE As a Tool to Analyze Lot-to-Lot Consistency of Complex TherapeuticProducts Such As BAX 855, a PEGylated Recombinant FVIII | Peter L. Turecek | Received |
58-Tu | Influence of expression of recombinant human ADAMTS13 in cell lines fromdifferent species on its glycosylation pattern and pharmacokinetics | Peter L. Turecek | Received |
58-Mo | Antihemophilic factors (AH) : comparative analysis and monitoring of spending atthe University Hospital of Dijon | ELODIE PHILIPPE | Received |
59-Tu | Establishment of a manufacturing process for recombinant human ADAMTS13retaining high specific activity | Peter L. Turecek | Received |
59-We | Safety of continuous rFVIII-FS infusions via 8-hour 250cc 0.9 IV bag | Angela Lambing | Received |
59-Mo | Disarray to Distinction: fast track restructuring of hemophilia care in HongKong. | Wing Au | Received |
60-Tu | Susceptibility of von Willebrand factor from different mammalian species tocleavage by human recombinant ADAMTS13 | Peter L. Turecek | Received |
60-Mo | Telemedicine in Haemophilia: Virtual Consultation for the haematologist atpatients home. | JOSÉ ANTONIO AZNAR | Received |
61-Mo | A project to establish a clinical and social assistance infrastructure inAfghanistan | Franco backhaus | Received |
62-Tu | Development of a large scale production process for BAX 855, a PEGylated rFVIIIproduct | Peter L. Turecek | Received |
63-Tu | Functional characterization of BAX 855, a PEGylated recombinant FVIII | Peter L. Turecek | Received |
64-Tu | Assessment of preclinical safety for BAX 326, Baxters recombinant human factorIX | Peter Turecek | Received |
65-Tu | Structural characterization of BAX 855, a PEGylated recombinant FVIII | Peter L. Turecek | Received |
65-Mo | How to manage a heamophilia treatment centre in an emergent country. TheMoroccan experience. | El Khorassani Mohamed | Received |
66-Mo | A National Infrastructure for Rare Blood Disorders: An Evaluation of Staffing,Training and Services in the US Federally-supported Hemophilia Treatment Centers | Ann Forsberg | Received |
66-Tu | Characterization of BAX 817 a recombinant FVIIa drug candidate | Peter L. Turecek | Received |
67-Tu | Characterization of BAX 326 a recombinant human factor IX drug candidate | Peter L. Turecek | Received |
67-Mo | Governing as governance in a NMO | Daniel-Aníbal García-Diego | Received |
68-Mo | Unique just like you | Eduardo Garzon | Received |
68-Tu | Safety of BAX 855, a polyethylene glycol (PEG) conjugated full-lengthrecombinant Factor VIII product | Peter Turecek | Received |
70-We | Restorative dentistry and third molar surgery in patient with an inhibitor toFVIII. A case report. | Bozidar Brkovic | Received |
71-Tu | Contribution of chromatography to virus and TSE removal in the FactorVIII/VWFOptivate process | Peter Feldman | Received |
71-Mo | From nothing to comprehensive hemophilia care -an experience of Karnataka Hemophilia Society | sandeep H S | Received |
71-We | Caries study, oral hygiene and changes on dental surfaces associated withfructose consumption in haemophilic patients and Von Willebrand | Evelyn González de Delgado | Received |
72-We | A review of dental surgical operations in 64 patients from a large haemophiliacentre in Northern India | Naresh Gupta | Received |
72-Mo | Strategic Advocacy program to involve Government in Hemophilia care: anexperience from India | Suresha Hanagavadi | Received |
73-Mo | Collaborative Working: The Newcastle Initiative | Chris James | Received |
73-We | Dental Surgery with minimal factor support update assessment of 120 patients | Ian Hewson | Received |
74-We | A specialized dental care programme for people with congenital coagulopathiesoffered in the Hemophilia Unit of Vall dHebron Hospital | Rafael Parra | Received |
74-Mo | Developing Recommendations for the UK Government on Haemophilia services & NHSReform | Chris James | Received |
74-Tu | USE OF HIGH DOSES FVIII/ VON WILLEBRAND FACTOR CONCENTRATE IN A PATIENT WITHTYPE III VON WILLEBRAND DISEASE AND HIGH LEVEL INHIBITOR | M Nieves Alonso Escobar | Received |
75-Mo | Encouraging positive change for people with bleeding disorders through a national awards scheme | Chris James | Received |
75-We | Periodontal management of Malagasy hemophiliacs | Simone RAKOTO ALSON | Received |
76-Mo | Asha Kiran - Summer camps to empower persons with hemophilia and their families. | Annamma Joseph | Received |
76-We | Oral Health Status and Oral Health Related Quality of Life in IranianHemophilic Pediatric Patients | Katayoun Salem | Received |
77-Mo | Kite flying - A unique idea for public awareness and fund raising. Experience from a rural hemophilia centre in India. | Annamma Joseph | Received |
77-Tu | Adaptation in hemophilia A patients during long term prophylactic treatment | Anna Balandina | Received |
78-We | A minimally invasive method for the diagnosis of lesions affecting the jaws | Federico Stolbizer | Received |
79-We | DENTAL MANAGEMENT OF CHILDREN WITH BLEEDING DISORDERS - THE KUALA LUMPURHOSPITAL EXPERIENCE | NORAINI NUN NAHAR YUNUS | Received |
80-We | Statistics of Dental Attention Provided to Pediatric Patients with Hemophiliaand Von Willebrand Disease at the Dental Clinic of the Hospital del Niño,Panama. | SOL LAIZ TORRES | Received |
80-Mo | Australia and New Zealand Inhibitors Workshop: Meeting the Challenges | Colleen McKay | Received |
81-Tu | Platelet procoagulant activity and thrombin generation in patients with severehemophilia | Amy Dunn | Received |
81-We | Through an ethical lens: ethics, pain management and family centered care | Liz Bishop | Received |
81-Mo | National educational programme in haemophilia in Ukraine | Galyna Moroz | Received |
82-Mo | Hemophilia patient outreach: Experience of Vietnam | Nguyen Thi Mai | Received |
82-We | Mothers of Children with Haemophilia: An Exploration of Their Experiences | Simon Brown | Received |
83-We | Understanding the challenges of distance and parenting a child with Haemophilia | Simon Brown | Received |
83-Mo | Twinning Programme between the Panamanian Foundation of Hemophilia and the CatalanAssociation of Hemophilia | Felipe Ortega | Received |
85-We | Guidelines for Growing: An action plan for parents of children with bleedingdisorders | Chad Feay | Received |
85-Tu | Concept Maps : an educational tool for teenagers with haemophilia ? | Céline Chenuel | Received |
85-Mo | MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCYDEPARTMENT | Gianna Franca Rivolta | Received |
86-Mo | Challenges Faced to Develop Comprehensive Hemophilia Care in India & its Remedies | DEVILA SAHU | Received |
87-Mo | The HEMONLINE Project: preliminary results | Gianluca Sottilotta | Received |
89-We | Re-PEP Programme in New Zealand - an opportunity to review, re-visit, reflectand refresh. | Colleen McKay | Received |
89-Mo | Improved hemophilia care in developing countries through the World Federation ofHaemophilia twinning programmes: the case of Yaoundé and Geneva | Tayou Tagny Claude | Received |
89-Tu | Evaluation of the therapeutic education of 35patients with hemophilia | Amina Krim | Received |
90-Tu | Developing the design of a educational game for children with Hemophilia. | MARCIA APARECIDA PICCOLOTO MATTA | Received |
90-We | Family issues faced by women with bleeding disorders and importance ofpsychological help in overcoming them | Priyanka Rawat | Received |
91-We | FACTOR IX SECRETION IN HUMAN ADIPOSE-DERIVED STEM CELLS BY NON-VIRAL GENETRANSFER | ANTONIO LIRAS | Received |
91-Tu | OPTIMIZE THE HEMOPHILIA ATTENTION, IN THE EMERGENCY ROOM, THROUGH A EDUCATIONMANUAL TO PRIMARY PHYSICIANS AND NURSES IN PANAMA | MORENO BELGICA | Received |
92-Tu | Severe Bleeding Disorder Alert Cards | Brian OMahony | Received |
93-Tu | MULTIDISCIPLINARY FORMATION AND TREATMENT IN HEMOPHILIA. A MEXICAN PILOT PROJECTCONTRIBUTION FROM THE HEALTH PSYCHOLOGY | Maricela Osorio | Received |
93-We | The impact of home treatment in the management of hemophilia in developingcountries | El Khorassani Mohamed | Received |
93-Mo | INTRACEREBRAL HEMORRHAGES IN PATIENTS WITH HEMOPHILIA: THREE YEARS OF FOLLOW-UPAT THE COMPREHENSIVE CARE PROGRAM IN CUBA (2008-2010). | Dunia de la Caridad Castillo González | Received |
94-Tu | Dont Push Your LuckBoard Game for Childrens Decision Making in their Hemophilia Care | Lisa Semple | Received |
95-Tu | HEMOPHILIA: TEACHING PROGRAM AT THE UNIVERSITY OF VALENCIA (SPAIN) | QUEROL FUENTES FELIPE | Received |
95-Mo | Clinical outcome in a cohort of HIV/HCV coinfected patients. HCV RNA presenceassociated to higher GGT levels. | Aloisi Zavala Natalia | Received |
96-Mo | Distribution of IL28b gene polymorphisms and presence of 32bp CCR5 deletion in acohort of HIV/HCV coinfected patients. | Maria Cecilia Monzani | Received |
96-Tu | The Development of a Tool to Assist Patients in Identifying Health Care Coverage- Personal Health Insurance Toolkit | Michelle Rice | Received |
96-We | Home clinical assistance: ITALIAN SURVEY OF HCA SUPPORT FOR THE MANAGMENT OF CVCIN PEDIATRIC HEMOPHILIC PATIENTS IN PROPHYLAXIS. | Ezio Zanon | Received |
97-Tu | Pedagogical practices with the use of Informatics resources for people withHemophilia | Cristiane Santos | Received |
97-Mo | Evaluation of liver fibrosis in haemophilia patients with HCV infection usingtransient elastography - Fibrotest. | Angelika Batorova | Received |
98-We | Effect of in vivo induction of regulatory T cells forimmune toleristaion andeffect on FVIII inhibitor anamnestic response | Simon Brown | Received |
99-We | Factor VIII product-dependent recognition of anti-factor VIII antibodies | Saulius Butenas | Received |
100-We | HOW MANY PATIENTS WITH HIGH-RESPONDING INHIBITORS DO/DID NOT UNDERGO IMMUNETOLERANCE INDUCTION IN ITALY? WHY NOT? | Antonio Coppola | Received |
101-Tu | NEW Teaching strategy: educational MANUAL of Hemophilia and VON WILLEBRAND forparents and patients in PANAMA. | VILLALAZ LUZ | Received |
101-We | RISK OF BLEEDING AND INHIBITOR DEVELOPMENT AFTER CIRCUMCISION OF PREVIOUSLYUNTREATED(PUPs) OR MINIMALLY TREATED(MTPs) SEVERE HEMOPHILIA A PATIENTS | Mohsen Elalfy | Received |
102-Tu | Development of an educational tool for haemophiliacs : advices of the pharmacist | Anne-Sophie Leromain | Received |
102-We | Plasma-exchange and immunosuppressive therapy in a patient with mild hemophiliaA and inhibitors complicated by severe muscular bleeding and compartmentalsyndrome | Chiara Ambaglio | Received |
103-Mo | The development of Japanese blood program for assuring safety in supplying domestic coagulation blood products: A case study of the Japanese Red Cross Society | Masatake Hongo | Received |
104-We | Presence and evolution of anti-factor VIII (FVIII) catalytic activity in severe,mild or moderate hemophilia patients with FVIII inhibitors | Sandrine Grosbois | Received |
104-Tu | Education: effective tool in the prevention of complications and appropriatemanagement of Haemophilias patient in Panama. | FRNCO ANAYANSI | Received |
105-Tu | BENEFITS FROM WHF TWINNING AND TEACHING PROGRAMS,OUR EXPERIENCE. | GUADALUPE VIVERO | Received |
106-Mo | Like a curse: Outcomes of the New Zealand 2011 People with Haemophilia andHepatitis C Survey | Chantal Lauzon | Received |
106-Tu | Use of short message service (SMS) to document bleeding episodes in childrenwith haemophilia | Carolyn Broderick | Received |
107-Tu | BLOOD 4 : A blog to cope with Hemophilia with the use of images | Frederica R.M.Y cassis | Received |
108-Tu | Remote Control: Is it enough? | Desdemona Chong | Received |
111-Mo | Number of Patients with Coagulation Disorders in Japans 2010 Annual Report fromthe Research Committee for the National Surveillance on Coagulation Disordersin Japan | SHINOBU TATSUNAMI | Received |
111-Tu | Social Network for Girls and Women with Bleeding Disorders | Cheryl DAmbrosio | Received |
112-Mo | The running infection of hepatitis C virus (HCV) diagnosis is too late in femalewith Severe Hereditary Clotting Factor Disorders (SHCFD): French single Centreexperience. | peynet peynet | Received |
113-Mo | An attempt to analyze the narrative world of the life-stories of doctors andpatients involved in the HIV tainted blood product incident in Japan | Masatake Hongo | Received |
114-Mo | Decrease of microparticles (MP) after the treatment in hemophilia A patients:Coincidence or causation? | Jovan P Antovic | Received |
114-Tu | Role of Telemedicine in managing Bleeding disorders in rural Pakistan | Tahira Zafar | Received |
115-Mo | Characterizing Global Hemostasis Throughout the FVIII Prophylaxis DosingInterval: A Pilot Study | Donald Brophy | Received |
116-Mo | A CIRCULATING HEPARIN-LIKE ANTICOAGULANT WITH NO BLEEDING COMPLICATIONS: CASE REPORT | Desiree Coen Herak | Received |
117-Tu | Successful Orthotopic Liver Transplantation in a Patient with Severe HaemophiliaA and High Titre Factor VIII Inhibitor | Richard Gregg | Received |
118-Mo | Hemophilia A prenatal diagnosis by factor VIII clotting activity usingpercutaneous umbilical blood sampling | Yunhai Fang | Received |
119-Mo | Haemophilia - a missed diagnosis | Naresh Gupta | Received |
119-We | Successful Immune Suppression Followed by Immune Tolerance Induction in a Factor9 Patient Who had Developed an Anaphylactic Reaction to Factor 9. | Nancy Hodgson | Received |
119-Tu | Life itself. Different visions of hemophilia | Otilia Ragull | Received |
120-Mo | Investigation of a prolonged APTT: Date from a UK NEQAS for Blood Coagulationexercise | Ian Jennings | Received |
120-We | Plasma Exchange and Continuous Infusion of Factor VIII for Life-Saving Surgeryin Hemophilia A with High-Titer Inhibitor: Two Case Reports | Rungrote Natesirinilkul | Received |
120-Tu | Caring for Mild Hemophilia: A Challenge to Comprehensive Hemophilia TreatmentCenters | M Dawn Goodyear | Received |
121-We | Successful low-dose immune tolerance induction regimen using multiple plasma-derived factor VIII concentrates. | Marina Pereira Colella | Received |
121-Tu | Development and Evaluation of a Self-assessment Pathway for Young Men with Mild Hemophilia | JoAnn Nilson | Received |
122-Mo | NEW QUANTITATIVE aPTT WAVEFORM ANALYSIS ON BEHRING COAGULATION SYSTEM | Marija Milos | Received |
122-We | IgG4 subclass of anti-FVIII antibodies is correlated to high-titer inhibitor,whereas IgG1 subclass is related to low-titer inhibitor in hemophilia Apatients. | Margareth Ozelo | Received |
123-We | Genetic risk factors for inhibitor development in a Brazilian severe hemophiliaA population | Margareth Castro Ozelo | Received |
123-Mo | UTILITY OF NEW QUANTITATIVE aPTT WAVEFORM ANALYSIS IN LABORATORY MANAGEMENT OFHEMOPHILIA A PATIENTS | Marija Milos | Received |
124-Mo | Validating the Role of Thrombelastography and the Thrombin Generation Assay forRoutine Clinical Care in Children with Haemophilia | Manfred Rauh | Received |
124-We | Sequential therapy with activated prothrombin complex concentrate andrecombinant factor VIIa in the treatment of unresponsive bleeding in patientswith hemophilia and inhibitors in a single center experience | Young Shil Park | Received |
125-Tu | The Royal Family: A Project to Increase Awareness of Hemophilia in Slovakia | Jaroslav Janovec | Received |
125-Mo | Modified Inverse shifting-PCR (IS-PCR) to investigate Intron 22 Inversion | federica riccardi | Received |
126-Mo | Molecular Analysis of mild haemophilia patients: the experience of a singlecentre | federica riccardi | Received |
126-Tu | Cerebral hemorrhage in a Malagasy with haemophilia B | AIMEE OLIVAT RAKOTO ALSON | Received |
127-We | Resolution of Nephrotic Syndrome Following Rituximab Therapy in a PatientUndergoing Immune Tolerance Induction | Susan Kearney | Received |
128-Tu | Bile Acid deficiency as cause of VKCFD in a Newborn | Matthias Watzka | Received |
128-We | Impact of HLA and cytokines polymorphisms on inhibitors development in childrenwith severe Haemophilia A | Helen Pergantou | Received |
129-Tu | Benefits of an Individual Communication Strategy from a National Haemophilia Society | Anne Duffy | Received |
129-Mo | Evaluation of Hemostatic Effect of BAY 86-6150, a Recombinant FVIIa Variant, inAntibody-Induced Hemophilic Whole Blood Under Flow Conditions | Mitsuhiko Sugimoto | Received |
130-We | Experience of surgery in patients with haemophilia with inhibitors | Tatiana Polyanskaya | Received |
131-Mo | Stability of clotting factors in fresh frozen plasma in the University TeachingHospital of Yaoundé, Cameroon | Tayou Tagny Claude | Received |
132-Mo | Thromboelastography as screening test for the diagnosis of Scott Syndrome. | paula villaca | Received |
132-We | Identification of potential T-cell epitopes in factor VIII using peptidemicroarrays | Kathleen Pratt | Received |
133-We | A Canadian survey on the incidence and risk factors for inhibitor development insevere hemophilia A PUPs: 2005-2010. | Georges-Etienne Rivard | Received |
134-We | F8 genotype and not polymorphisms in IL10, TNFA and CTLA4 influences inhibitor development in Argentine patients with severe HA. | Liliana Rossetti | Received |
135-We | Circumcision experience in severe hemophilia patients with inhibitors | Sasmaz Ilgen | Received |
136-Mo | Heterozygote frequencies of common polymorphic markers of factor VIII (F8) and factor IX (F9) genes in indigenous Nepali population | Shrimati Shetty | Received |
137-We | Prospective ADVATE Immune Tolerance Induction Registry (PAIR) in Hemophilia APatients with Inhibitors: Interim Report | Gerald Spotts | Received |
138-We | ALLELE POLYMORPHISMS OF IMMUNE RESPONSE GENES IN SEVERE HAEMOPHILIA A PATIENTSWITH INHIBITORS IN UKRAINE | Oleksandra Stasyshyn | Received |
138-Mo | Various genetic mechanisms resulting in phenotypic expression of haemophilia A in three females | Virginie Barbay | Received |
139-We | Case series report - low-dose immune tolerance (ITI) in Iran | shirin Tehrani Tarighat | Received |
140-Mo | Duplications Xq28 and Hemophilia are questionable for genetic counselling | Catherine Costa | Received |
140-Tu | Differences in the Bleeding Phenotypes of Haemophilia A and B | Berthold Siegmund | Received |
141-Mo | Spectrum of mutations in 407 unrelated haemophilia B patients | Costa Catherine | Received |
143-Mo | A third rearrangement caused by homologous recombination between inverted repeats at Xq28 cause severe hemophilia A | Behnaz Pezeshkpoor | Received |
145-Mo | Inversion 22 in Hemophilia A in the North Indian Population: a New cDNA BasedProtocol | Praveen Kumar | Received |
145-We | Genotype-phenotype Correlation in Hemophilia A and Risk of Inhibitors of F8 genemutations | kiyoung yoo | Received |
145-Tu | The method of concentration of blood clotting factor VIII usingcross-galvanization in patients with hemophilia A | Kate Kabaeva | Received |
146-Tu | A New Clinical Tool to Measure Balance and Mobility in Hemophilia: the CommunityBalance and Mobility Scale. | Cecily Bos | Received |
149-Mo | INTRACELLULAR TRAFFICKING ANALYSIS OF C111Y AND C111S MUTATIONS IDENTIFIED INFACTOR IX FROM MEXICAN PATIENTS WITH SEVERE HEMOPHILIA B | JOHANNA MANTILLA CAPACHO | Received |
149-We | Prevalence of inhibitor antibodies in the Mazandaran(North of Iran) haemophiliaA population. | Hassan Mahmoodi Nesheli | Received |
150-Mo | GENETICS DEFECTS IN VON WILLEBRAND DISEASE. | Rosario Pérez Garrido | Received |
150-We | USE OF FACTOR VIII CONCENTRATES IN LIFE-THREATENING BLEEDING IN HEMOPHILICPATIENTS WITH INHIBITOR | Hugh C Kim | Received |
150-Tu | ADVATE HaEmophlia A Outome Database (AHEAD): A long-term registry focusing onjoint health outcomes and health-related quality of life | Gerald Spotts | Received |
151-Tu | A Post-Authorisation Safety Surveillance of ADVATE, Recombinant Antihemophilic Factor, Plasma/Albumin-Free Method (rAHF-PFM) in Hemophilia A | Jenny Chou | Received |
151-We | Intracranial Hemorrhage (ICH) in a 5-years-old Child with Severe Hemophilia Band Inhibitors with Anaphylaxis: Treatment Issues | Carvalho Manuela | Received |
151-Mo | Absence of active F8 protein despite high F8 mRNA expression levels in a severeHaemophilia A patient | Behnaz Pezeshkpoor | Received |
152-We | Prevalence of inhibitor in a prospective cohort of hemophilic children under 4years of age from a single center. | Florencia Tisi Baña | Received |
152-Mo | IDENTIFICATION OF MUTATIONS ASSOCIATED WITH HAEMOPHILIA A: A FRENCH CARIBBEANEXPERIENCE | Serge PIERRE-LOUIS | Received |
152-Tu | Estimated Annual Infusion Volume Reduction with a 2 mL Reconstitution Volume forADVATE | josh epstein | Received |
153-Mo | The Canadian National Program for Hemophilia Mutation Testing database: aten-year anniversary review. | Natalia Rydz | Received |
153-We | Successful use of negative pressure wound therapy in a patient with severeHemophilia A and an inhibitor | Vicky Hanneman | Received |
154-Tu | Pain in Haemophilia. Assessment of type of pain, coping styles and analgesicuse. | bj ramsay | Received |
155-We | RADIOACTIVE SYNOVECTOMY of the SHOULDER JOINT in PATIENTS with HAEMOPHILIA | Semih Aydogdu | Received |
155-Tu | Pain and Meaning: from the injury to the experience of pain | Ceres Lotito | Received |
156-Mo | Clinical implementation of Clinician-oriented locus specific mutation detectionand deposition system | kiyoung yoo | Received |
156-We | The management of domiciliary acute haemarthrosis by ultrasonography: experiencein a single center. | AZNAR LUCEA JOSE ANTONIO | Received |
157-We | Autologous stem cell treatment in hemophilic arthropathy. | Aymara Baganet Cobas | Received |
158-We | KNEE ON FLEXION: OSTEOTOMY OF FEMORAL EXTENTION IN PEDIATRIC PATIENTS WITH HAEMOPHILIA | ROBERTO BERNAL-LAGUNAS | Received |
159-Mo | Gene rearrangements and mutations in Malaysian patients with Haemophilia A | maimiza zahari | Received |
159-We | Abnormal inter-extremity difference (AIED) of quadriceps muscle strength and relationship to patellar tendon thickness and joint status in PWH | Alexander Brunner | Received |
159-Tu | Central Venous Line Insertion and Factor Replacement Therapy in Patients with Haemophilia A: a local experience. | Adriana Fonseca | Received |
160-Tu | Obesity management in boys with severe haemophilia: What works? | Nicola Hamilton | Received |
161-Mo | Role of nurse in improving hemophilia care | Fayal Bouaballou | Received |
162-Mo | Inherited Bleeding Disorders- The Nursing Experience of Patient and Family CareNeeds in the Paediatric Setting. | Gill Doyle | Received |
163-Tu | Constraints and challenges in treating a young haemophiliac with exceptionallyhigh inhibitor titers. | Andromachi Papagianni | Received |
163-Mo | The needs and support measures of Japanese haemophilic careers(JHC): discussionfrom literature review. | tomie fujii | Received |
165-We | Frequency , risk factors and consequences of Decreased Bone mineral Density inchildren with Hemophilia A and B | PEYMAN ESHGHI | Received |
165-Tu | A Survey of Current Canadian Practice in the Care of Newborn Boys withHemophilia | Paul Moorehead | Received |
165-Mo | Evaluation of methods of identifying carriers of haemophilia. | Anne Gillham | Received |
166-We | Pseudotumours in mild haemophiliacs - a rare pathology. | joanna farrant | Received |
168-Mo | Optimising health outcomes for childrenliving with Haemophilia in rural communitiesby forging partnerships betweenHaemophilia Treatment Teams and Local Health Networks | Anne Jackson | Received |
169-We | Total Knee Replacement in patients with Hemophilia - a follow-up of 30 patients | Bjoern Habermann | Received |
170-We | Autologous Chondrocyte Implantation in a patient with severe Hemophilia | Bjoern Habermann | Received |
172-Mo | Using motivational interviewing techniques to enhance therapeutic relationshipswith adult and pediatric hemophilia clients | Lois Logie | Received |
172-We | Iliopsoas haemorrhage in patients with haemophilia. | Denisa Jankovic | Received |
173-Mo | A Successful Model of a Nursing Short Message System (SMS) for ImprovingHemophilia Care in South China | Jing SUN | Received |
173-Tu | Preclinical safety pharmacology of a PEGylated variant of recombinant factor VIII | Eva Muchitsch | Received |
174-Tu | Pharmacokinetics of a Recombinant Factor VIIa in Factor VIII ko Mice, Rats andMacaques | Eva-Maria Muchitsch | Received |
174-We | ETPS - AN EFFECTIVE MODALITY IN CHRONIC SYNOVITIS TO ENHANCE ACTIVITY | Dr. Jayashri Kale | Received |
175-Tu | Single Dose Pharmacokinetics of a PEGylated Variant of Recombinant FVIII inFactor VIII ko Mice, Rats and Macaques | Eva-Maria Muchitsch | Received |
175-We | Factor IX (FIX) deficiency and a swollen knee: not always a bleed | Susan Karp | Received |
176-Tu | Single Dose Pharmacokinetics of Recombinant FIX in Factor IX ko Mice, Rats andMacaques | Eva-Maria Muchitsch | Received |
176-Mo | Networking in Hemophilia and other Bleeding Disorders Care:The Canada-Germany Nurse Experience | Nancy Hodgson | Received |
177-Tu | Preclinical safety pharmacology of a new recombinant factor IX | Eva Muchitsch | Received |
178-Mo | Self-modification of Regimens by Hemophilia Patients in Japan | Kayoko Omura | Received |
178-Tu | Evolution of management of pregnancies at-risk for haemophilia in France in the last ten years: Impact of non-invasive foetal sex determination | Catherine Costa | Received |
179-We | Radiosynovectomy in Chronic Recurrent Haemophilic Haemarthrosis: The NorthEastExperience. | Munir Khan | Received |
180-We | Results of ankle prosthesis in patients with severe haemophilic arthropathy -follow up | Manuela Krause | Received |
180-Mo | EXPERIENCE IN VENOUS CENTRAL CATHETER (PORT-A-CATH) IN PEDIATRICS, FORTREATMENT OF HEMOPHILIA AND VON WILLEBRAND DISEASE IN PANAMA. | VILLALAZ LUZ | Received |
181-Mo | Experience of the use of Veinviewer for DIVA patients with hemophilia | kiyoung yoo | Received |
182-Mo | Case report of Heart surgery of the patient with bleeding disorder | roxana kabiri movahhed | Received |
182-We | Joint Preservation Post Ankle Arthrodesis in Hemophilia: A Review | Heidi Lane | Received |
182-Tu | Observational study for improving adherence with prophylaxis in haemophilia | KAGEHIRO AMANO | Received |
183-We | Outcomes in Activity, Participation and Body Structure Following AnkleArthrodesis in Persons with Hemophilia: Analyses Using the Universal DataCollection Surveillance Project | Heidi Lane | Received |
183-Mo | QUALITY OF LIFE FOR PATIENTS WITH HEMOPHILIA | Glbahar Keskin | Received |
184-We | Intra-Articular Hyaluronic Acid in Treating of Haemophilic Knee Arthropathy | Tsung-Ying Li | Received |
184-Tu | SECONDARY PROPHYLAXIS IN ADULT SEVERE HAEMOPHILIC PATIENTS: A PROSPECTIVE STUDYIN A SINGLE CENTER. | JOSÉ ANTONIO AZNAR | Received |
185-Mo | Study of adherence to prophylactic treatment in severe A haemophilic patients | JOSÉ ANTONIO AZNAR | Received |
185-Tu | Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling of Factor VIII (FVIII) Usingits Plasma Concentration and Global Hemostasis Biomarkers: | Donald Brophy | Received |
185-We | Haemophilic Arthropathy and Health-Related Quality of Life in Haemophilic Patients in Taiwan | Tsung-Ying Li | Received |
186-Tu | COMPARISON TWO LABORATORY ASSAYS IN MONITORING EFFICACY OF DIFFERENTPROPHILAXIS REGIMENS FOR SEVERE HAEMOPHILIA | Irena Djunic | Received |
187-Tu | Successful Secondary Prophylaxis in Haemophilia with Inhibitors using rFVIIaThree Times per Week | Monica Martinez | Received |
188-Tu | Bleeding Patterns In Severe Hemophilia A Infants and Toddlers On Prophylaxis VsOn Demand Therapy:A Prospective Randomized Observational Study | Mohsen Elalfy | Received |
188-We | SUBPERIOSTEAL/INTRAMUSCULAR PSEUDOTUMOUR- SURGICAL TREATMENT BY INTRALESIONALCURRETTAGE OR WIDE EXCISION | SHUBHRANSHU MOHANTY | Received |
189-We | Hemarthrosis results in an increase in Synovial Fibrinolytic activity in Hemophilia Mice | laurens nieuwenhuizen | Received |
189-Mo | Multicenter study of pediatric quality of life and psychomotor development inparents of children with severe and moderate hemophilia who receive primaryprophylaxis treatment in public hospitals in Chile | Claudia Bularte | Received |
190-We | Identification - and differences in expression - of the iron regulatorsFerroportin, Hepcidin, Hemoglobin Scavenger Receptor CD163, Heme Carrier Protein1, and Heme Exporter FLVCR in Healthy, Osteoarthritic, Rheumatoid, andHemophilic Synovium. | Laurens Nieuwenhuizen | Received |
190-Mo | The Impact of Pediatric Psychology on Identification of Psychosocial Needs | Cathliyn Buranahirun | Received |
191-Mo | Pedagogical attention programme. Results after 18 year s experience. | Patricia Cabré | Received |
192-Tu | Adherence to Prophylaxis Treatment Regimens among Persons with Severe Hemophilia A and B: Results from a 1-Year, Single Institution Study | Miguel Escobar | Received |
192-Mo | Social Participation in Boys with Hemophilia | Aubrey Chiu | Received |
193-We | Prospective Evaluation of Safety and Efficacy of Radioactive Synovectomy with90Yttrium-Hidroxyapatite and 153Samarium-Hidroxyapatite in Chronic HemophilicSynovitis | JANAINA BOSSO J SILVA | Received |
193-Tu | Prophylaxis with increasing doses, our experience about 8 cases | FAIZA MEZHOUD | Received |
194-We | Conservative Treatment of Severe Knee Flexion Contracture in Two Patients withSevere Hemophilia A Patients with High-responding Inhibitors | Margareth Ozelo | Received |
195-We | Surgical treatment of the hemophilic pseudotumor:a single center experience | Joannis Panotopoulos | Received |
195-Mo | Childhood and subjective timings: growing up with hemophilia | Silvia Grases | Received |
196-Mo | Psycho-social issues in haemophilia- 100 case studies | Naresh Gupta | Received |
196-Tu | SECONDARY PROPHYLAXIS IN HEMOPHILIAC ADULTS WITH ARTHROPATHY. DESCRIPTION OF ACOHORT. | Carlos Ramírez | Received |
197-Tu | SECONDARY PROPHYLAXIS WITH ANTI INHIBITOR COAGULANT COMPLEX (AICC): FROMANECDOTE TO REALITY | Maria Helena Solano | Received |
197-Mo | :Psychosocial Issues-support for People With Hemophilia & their families inIndia: | Meera Suresh Hanagavadi | Received |
198-Tu | Tailored primary prophylaxis with dose-escalation in Iranian haemophilia A | shirin Tehrani Tarighat | Received |
198-Mo | THE PSYCHOLOGY WORK AT CENTRO DOS HEMOFLICOS DO ESTADO DE SO PAULO - CHESP | Reiko Hanashiro | Received |
199-We | ULTRASONOGRAPHY PROTOCOL FOR DIAGNOSIS AND CONTROL OF ACUTE HEMARTHROSIS INHAEMOPHILIC PATIENTS | QUEROL FUENTES FELIPE | Received |
200-We | Does prophylaxis have an effect on bone strength beyond physical activity? | Anne Mkipernaa | Received |
201-Tu | Long-term low-dose secondary prophylaxis for severe and moderate hemophiliachildren with arthropathy: A single-center prospective study in China | Ada Xu | Received |
202-Tu | Hemophilic arthropathy in pediatric patients with hemophilia A: comparison ofearly and late prophylaxis. | kiyoung yoo | Received |
202-Mo | Restructuring and improving QOL in Japanese HIV victims with hemophilia andtheir families: How do we rebuild our life with effective support? | Akiko Kakinuma | Received |
203-We | Bone mineral density in hemophiliac patients | Nader Roushan | Received |
204-Tu | Prophylaxis vs. On Demand Treatment in Adults with Severe Hemophilia A. | Cecily Bos | Received |
206-Mo | Mind Inhibitors | Walid Kobisi | Received |
206-Tu | What do Canadian men living with Hemophilia need to know to facilitate optimaldisease management? A mixed methods approach | Shannon Lane | Received |
207-Tu | The Effect of yoga technique on quality of life in children and adolescentswith haemophilia referring to Dastgheib hospital .1389 Shiraz University OfMedical Siences SHIRAZ-IRAN | Noushin Beheshtipoor | Received |
208-We | Long-term studies of hemophilic arthropathy by Petterssons score - Evidencesthat joint damages in hemophiliacs occur predominantly in early years of life | Ming-Ching Shen | Received |
208-Mo | A NEW TOOL TO ASSESS COPING AND PERCEPTION OF CHILDREN WITH HAEMOPHILIA | Perrine Limperg | Received |
209-Mo | HEALTH RELATED QUALITY OF LIFE OF BOYS WITH HAEMOPHILIA AND PARENTS ILLNESS PERCEPTIONS | Perrine Limperg | Received |
210-We | Age-related changes of joint status in adults with severe haemophilia in Germany | Franziska Staeuber | Received |
211-Mo | Social support and economic stability as major determinants of self-esteem amongpersons with hemophilia | Marko Marinic | Received |
211-Tu | Quality of life of hemophilic children on prophylactic or on demand treatmentregimens in Iran | PEYMAN ESHGHI | Received |
212-Tu | The Place of the Pictorial Blood Assessment Chart in the appreciation of qualityof life in women with inherited bleeding disorders. | Anis Fadhlaoui | Received |
212-We | Osteochondral lesions of the ankle joint in patients with hemophilia A. A retrospective case series. | Karen Strike | Received |
213-Tu | Quality of life during menstruations in women with inherited bleeding disorders(About 31 patients) | Anis Fadhlaoui | Received |
213-Mo | A 10-year follow up of an HIV/HCV co-infected hemophilia A after living donorliver transplantation | Eiichi Mizukoshi | Received |
214-Mo | At a loss as to where to go from here? | Daryl Pollock | Received |
215-We | Arthroscopic synovectomy with joint distraction using a patella tendon bearingbrace for severe hemophilic ankle arthropathy | YASUHITO TANAKA | Received |
215-Mo | Oral Mucosal Bleeding: A Nurses View | bj ramsay | Received |
216-Tu | FACTORS RELATED TO QUALITY OF LIFE IN HEMOPHILIA PATIENTS. | Miwa Goto | Received |
216-We | Radiosynovectomy with Yttrium and Samarium. 488 patients/842 injections. Preliminary report on radiation safety | Sylvia Thomas | Received |
216-Mo | Youth With Hemophilia In Pakistan | Sheikh Moin Riaz | Received |
217-Tu | Health Related Quality of Life Among Hemophilia Patients in North East Region ofIndonesia | Stefanus Gunawan | Received |
217-We | Blood coagulation aggravates joint damage after an experimental hemorrhage in acanine knee | Monique van Meegeren | Received |
218-We | Four-day continuous blood exposure leads to prolonged joint damage in a caninein vivo model, whereas intermittent blood exposure does not | Monique van Meegeren | Received |
219-Mo | Psychosocial Issues and support for PWH & their families in India | Meera Suresh Hanagavadi | Received |
220-Mo | COMPARATIVE STUDY OF FUNCTIONING FAMILY IN PATIENTS WITH HEMOPHILIA AND OTHERFAMILIES WITH DISEASE | Ana Torres-Ortuño | Received |
221-Mo | SCHOOLS OF FAMILIES FOR PARENTS OF CHILDREN WITH HEMOPHILIA | Ana Torres | Received |
223-We | Experimental evaluation of cartilage damage by hematic synovitis in rabbits byNuclear Magnetic Resonance control | Ana Laura Douglas Price | Received |
223-Mo | The Psychologic and Disease burden assessment in hemophilia children witharthropathy: a single-center study in China | Ada Xu | Received |
223-Tu | PATIENT REPORTED OUTCOMES IN CLINICAL HAEMOPHILIA PRACTICE | Perrine Limperg | Received |
224-We | PRELIMINARY RESULTS OF A PHYSIOTHERAPY PROTOCOL IN THE SECONDARY PROPHYLAXIS OFADULTS WITH HAEMOPHILA | QUEROL FUENTES FELIPE | Received |
224-Tu | Income and Anxiousness of Working Hemophiliacs in Japan | Takeshi Matsumoto | Received |
225-Tu | Treatment outcome in young adults survey of 8 Countries - Preliminary Results | Brian OMahony | Received |
226-Mo | Auto care for childrens | YURI ANDREA ARANGO BERNAL | Received |
227-Tu | HEALTH RELATED QUALITY OF LIFE (HrQoL) IN BLEEDING PROPHYLAXIS WITH AN ACTIVATEDPROTHROMBIN COMPLEX CONCENTRATE (APCC): RESULTS FROM THE PRO-FEIBA STUDY | silvia riva | Received |
227-Mo | ECONOMIC AND PSYCHO-SOCIAL CARE FOR HAEMOPHILIA PATIENTS IN MARTINIQUE, A FRENCHCARIBBEAN EXPERIENCE | Serge PIERRE-LOUIS | Received |
228-Tu | Linking Quality of Life Measures with the ICF/ICF-CY in Young People withHaemophilia | silvia riva | Received |
228-Mo | Screening of the Von Willebrand disease in the west Algeria. | BENLALDJ DRISS | Received |
229-We | A baseline assessment of physical disabilities in 372 haemophilia patients inNorthern India | Naresh Gupta | Received |
229-Tu | Difficulties faced by haemophilic students in Japan | Yukiko Seki | Received |
230-Tu | Description of a Canadian Cohort of Youth and Young Men with Hemophilia Based onHealth-Related Quality of Life Measures. | Jean St-Louis | Received |
230-We | Hemophilia at Physical Medicine and Rehabilitation, assessment of physical,functional and psychological aspects: Prospective study conducted at Oran hospital - Algeria | khaled layadi | Received |
231-Mo | SINGLE CENTRE EXPERIENCE OF THE GP1B LATEX IMMUNOASSAY AND RISTOCETIN COFACTOR ASSAY - A COMPARATIVE STUDY. | David Davies | Received |
231-Tu | Impact of Life Events and Transitions on Health-Related Quality of LifeMeasurements in Youth and Young Adults with Hemophilia. | Jean St-Louis | Received |
232-Tu | Quantitative word mapping of hemophiliac patients opinions based on free-answerdescriptions on a quality-of-life questionnaire | SHINOBU TATSUNAMI | Received |
232-We | Assessment of Functional Independence Score In Hemophilia in Indian Children with Hemophilia | Sandeep H S | Received |
233-Mo | PARAPROTEIN SPECIFIC BINDING FOR PLATELET RECEPTOR GLYCOPROTEIN Ib AS A CAUSE OFACQUIRED VON WILLEBRAND SYNDROME IN MONOCLONAL GAMMOPATHIES | Irena Djunic | Received |
234-Tu | Understanding the Impact of Hemophilia on the Family: A Pilot Study of thePedsQL-Family Impact Module | Vicky Breakey | Received |
234-Mo | Expression Studies of von Willebrand Factor Missense Mutations Causing Type 1 orType 2 VWD | Hamideh Yadegari | Received |
235-Tu | Has the quality of life improved for children with haemophilia A? | Vaughan Williams | Received |
236-We | Strength training and stretching muscles of lower limbs in patients withhemophilia and arthropathy of the ankle. A pilot study. | RUBÉN CUESTA-BARRIUSO | Received |
236-Tu | HAEMO-QOL QUESTIONNAIRE FOR ADOLESCENTS: ASSESSING THE ITEM BLEEDING | Claudia Lorenzato | Received |
237-Tu | QUALITY OF LIFE IN RELATION TO SOCIAL AND EMOTIONAL SELF CONCEPT AND LIFE SATISFACTION | Luis Vañó Gisbert | Received |
237-We | Efficacy and safety of traction articular ankle arthropathy. A pilot study | RUBEN CUESTA-BARRIUSO | Received |
238-We | Clinical improvement of chronic arthropathy of the knee with manual therapy. Apilot study. | RUBÉN CUESTA-BARRIUSO | Received |
238-Tu | Swimming as a strategy to promote rehabilitation, physical fitness, mentalhealth and social inclusion to people and families suffering of Hemophilia andVon Willebrand. | YURI ANDRES ARANGO BERNAL | Received |
238-Mo | A pregnant woman with von Willebrand disease (VWD) type 2B: laboratory findingsand peripartal bleeding management | Katharina Holstein | Received |
239-We | In-hospital rehabilitation after multiple joint procedures (MJP) of the lowerextremities in persons with hemophilia (PWH) | Piet Kleijn, de | Received |
239-Tu | Psychometric properties of the Quality of Life Questionnaire in PediatricPatients with Hemophilia Mexico (QoLHMEX) | Maricela Osorio | Received |
240-Tu | Online Anthology of Individual Experiences by Girls and Women with BleedingDisorders | Cheryl DAmbrosio | Received |
240-Mo | Clinical diagnosis and laboratory screening in vWD pediatric patients of theNorthwestern of Mexico | Ana Rebeca Jaloma-Cruz | Received |
240-We | The Use of a Carbon-fiber Ankle Foot Orthosis and Therapeutic Exercise forManaging Pain in An Adolescent with Severe Blood-induced Ankle Joint ArthropathySecondary to Type 3 von Willebrand Disease | Sharon Funk | Received |
241-We | Recovery of the gait ability after total knee arthroplasty | Minoru Kubota | Received |
242-Mo | On demand therapy after ITT failure in a patient with von Willebrand diseasetype 3 and alloantibodies | Manuela Krause | Received |
243-We | Use of the Exergaming (Nintendo Wii) in the Rehabilitation of Patients withHemophilia. | JANAINA BOSSO JOSÉ DA SILVA | Received |
243-Tu | Prophylactic treatment in factor XI deficiency patients undergoing invasiveprocedures. | Philippe BEURRIER | Received |
244-We | Postural control in children with hemophilia. | Fabio Souza | Received |
245-We | Successful treatment outcome for an eight year old hemophilia boy withChronic Regional Pain Syndrome (CRPS) | Rachel Tiktinsky | Received |
245-Tu | Rare Inherited Bleeding Disorders: from a single centre in Pakistan. | MUNIRA BORHANY | Received |
246-Tu | Mutations causing severe Factor XIII deficiency in Pakistan | MUNIRA BORHANY | Received |
247-Mo | Prevalence of von Willebrand disease in Koreans | Sangkyu Park | Received |
247-We | The effect of 8-week aquatic exercise on Strength, Balance and Gait speed inhemophilia | kiyoung yoo | Received |
248-We | Improvement of walking ability of three inhibitors by rehabilitation | shimokawa akikko | Received |
249-Mo | Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease. | Natalia Rydz | Received |
250-Tu | The Canadian Experience: Severe Factor V Deficiency | M Dawn Goodyear | Received |
251-We | Serial casting on deformity with excercises is more effective than conventionalphysiotherapy treatment in people with hemophilia | Geeta Suri | Received |
252-We | THE OXIDATIVE STRESS AND ANTIOXIDANT STATUS AT CHILDREN WITH IMMUNETHROMBOCYTOPENIC PURPURA: ENDOTHELIAL NITRIC OXIDE SYNTHASE Glu298Asp GENEPOLYMORPHISM | Saadet Akarsu | Received |
253-Mo | Molecular Pathology of severe von Willebrand disease in Indian population | Shrimati Shetty | Received |
253-We | NORMAL PLATELET PARAMETERS IN CHILDHOOD PERIOD FROM NEWBORNS TO ADOLESCENTS | Saadet Akarsu | Received |
253-Tu | Laboratory Diagnosis of FXIII deficiency: Data from a UK NEQAS (BloodCoagulation) exercise | Ian Jennings | Received |
254-Mo | Polymorphic markers in VWF gene: Application in genetic diagnosis of affectedfamilies with VWD | Shrimati Shetty | Received |
255-We | Hemarthrosis an Unusual Presentation of Glanzmanns thrombasthenia | Bijan Keikhaei | Received |
256-Tu | Inherited Factor VII deficiency - perioperative replacement therapy is notnecessary in most cases | Robert Klamroth | Received |
256-Mo | Development of an automated VWF:RCo assay for measuring plasma samples with lowactivity | Peter L. Turecek | Received |
257-Mo | Analysis of the French cohort of 65 patients with type 2N von Willebrand diseaseidentifies distinct molecular/clinical entities. | Agnès VEYRADIER | Received |
258-Mo | French cohort of 37 patients with type 3 von Willebrand disease: molecular andclinical features | Agnès VEYRADIER | Received |
258-We | Identification of 5 new mutations in 9 Glanzmann Thrombasthenia patients | Ann-Kathrin Pilgrimm-Thorp | Received |
259-Tu | Factor XIII deficiency in Sistan and Baluchestan of Iran | Majid Naderu | Received |
260-Tu | Frequency & clinical spectrum of rare bleeding disorder in Pakistan,A multi centre study | Arshi Naz | Received |
260-We | Neurosurgery in a patient with Bernard-Soulier Syndrome | Elianna Saidenberg | Received |
261-Mo | Persistent acquired von Willebrand disease cases despite underlying neoplasmaremission. | Maria Eva Mingot Castellano | Received |
261-Tu | PROPHYLACTIC TREATMENT WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE IN APATIENT WITH SEVERE FACTOR X - FX- DEFICIENCY. | Jorge Peña Siado | Received |
262-We | 5 years Treatment report of hospitalized children with Glanzmannsthrombasthenia in a comprehensive hemophilia care center (2006-2011) | PEYMAN ESHGHI | Received |
262-Tu | Phenotypic classification of the mutations in coagulation factor IX segregate to different locations in its protein structure | Pavithra Meena Rallapalli | Received |
262-Mo | Thrombosis in patients with von Willebrands disease | Mirjana Mitrovic | Received |
263-Mo | Pregnancy outcomes in women with, and carriers of, inherited bleeding disordersin a London obstetric unit with Haemophilia Comprehensive Care Centre. | Imelda Balchin | Received |
264-Tu | Genotype-Phenotype correlation in families with mild factor VII deficiency | federica riccardi | Received |
265-Mo | CODEROUGE 2012 - 1st CANADIAN CONFERENCE ON BLEEDING DISORDERS IN WOMEN | Clare Cecchini | Received |
265-We | Physical and psychosocial benefits of exercise for patients with haemophilia | Lisa Blain | Received |
266-We | Haemophilia & Exercise Project (HEP): Subjective and objective physical performance in adult haemophilia patients after one year sports therapy programme | Doerte Czepa | Received |
268-Tu | THROMBOSIS OF THE ABDOMINAL AORTA IN CONGENITAL AFIBRINOGENEMIA. | Maria Teresa sartori | Received |
268-We | Development of a bleeds risk calculator | Rob Herbert | Received |
269-Mo | Current Postpartum Treatment Strategies for Von Willebrand Disease May NotAdequately Replace von Willebrand Factor | Andra James | Received |
269-Tu | Efficacy of a Recombinant ADAMTS13 in a Mouse Model of ThromboticThrombocytopenic Purpura | Eva-Maria Muchitsch | Received |
270-Mo | Pregnancy outcome of women with congenital bleeding disorders managed bymultidisciplinary team in a UK Haemophilia Comprehensive care centre over 3-yearperiod | DEEPA ARACHILLAGE | Received |
270-Tu | Delayed vitamin k deficiency related bleeding : is it genetically linked ? | Shrimati Shetty | Received |
270-We | Patterns of physical activity in Australian children with haemophilia. | Jane Latimer | Received |
271-Tu | Intracranial hemorrhage in an infant with severe Factor V deficiency | Jayson Stoffman | Received |
271-We | Quantifying the challenge: Proposal for evaluation of musculoskeletal system inswimmers with hemophilia undergoing intensive training. | MARIA MATILDE ROSAS CHACON | Received |
272-Tu | Factor XI deficiency: importance of von Willebrand factor level on haemorrhagicphenotype. | Fabienne VOLOT | Received |
272-We | Importance of Youth Groups in an National Member Organization | MUKESH GARODIA | Received |
274-Mo | Haemostatic Variations in Normal Women: The Role of Electronic Bleeding Questionnaire, Electronic Pictorial Chart and a Global Haemostatic Assay in Predicting Mild Bleeding Disorders in Women | Kimberly MacEachern | Received |
274-We | Understanding health and treatment decision making among youth with hemophilia:a qualitative approach | Shannon Lane | Received |
275-We | Participation of Children in National Haemophilia Conferences | Brian OMahony | Received |
275-Mo | Hematological and Gynecological Assesment in Haemophilia Carriers | Carlos Ramírez | Received |
276-Mo | Successful IVF and pregnancy in Glanzmanns thrombasthenia under cover of recombinant factor VIIa | Peter Staritz | Received |
276-Tu | Molecular analysis of congenital factor XI deficiency by High-Resolution Melting | federica riccardi | Received |
277-Mo | A Strategy for Women with Bleeding Disorders The Irish Experience | Debbie Greene | Received |
277-We | A Feasibility Study of Managing Hemophilia Online, An Internet-basedself-management and transitional care program for teens. | Vicky Breakey | Received |
278-Tu | Are They Really Rare?Prevalence of Rare Bleeding Disorders (RBDs) in North East of Iran | Zahra Badiei | Received |
279-We | Patients attitude to dental care | Andrew Brewer | Received |
296-LB | Evaluation of a 4-year External Quality Assessment Program on the Laboratory Diagnosis of Hemophilia in Brazil | Silmara Aparecida Lima | Received |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||